Entries in Biopsy
(2)

Photo Courtesy - Getty Images(DAVIS, Calif.) - New research suggests that more than a quarter of women with presumed early-stage ovarian cancer are at an increased risk of death because they do not get recommended biopsies, reports HealthDay News.

Researchers at the University of California Davis Cancer Center and California Cancer Registry found that records of 721 apparent early-stage ovarian cancer patients showed that just 72 percent had the recommended lymph nodes biopsies, which can reveal whether cancer has spread.

A further review found that the five-year survival rate for those who did not receive the biopsies was 69 percent, compared to 84 percent for patients who underwent the biopsies.

Photo Courtesy - Getty Images(VANCOUVER, British Columbia) -- Detecting cancerous moles could soon take a matter of seconds, thanks to a new device by Verisante Technology.

The device, called the Verisante Aura, is held above a suspicious mole and scans for 21 cancer biomarkers in under a second. The technology works by utilizing Raman spectroscopy, which determines a mole's spectral signature.

The device will now head to the Food and Drug Administration and Canada Health for testing and confirmation. Even if the device wins approval, however, it is not expected to take the place of traditional biopsies, but rather be used for preliminary testing.

Traditionally, moles that are expected to be cancerous are removed and sent to a lab for testing, a process that takes a much longer period of time.